318 related articles for article (PubMed ID: 25824409)
21. Oestrogen treatment enhances the sensitivity of hormone-resistant breast cancer cells to doxorubicin.
Scherbakov AM; Lobanova YS; Andreeva OE; Shatskaya VA; Krasil'nikov MA
Biosci Rep; 2011 Apr; 31(2):137-43. PubMed ID: 20662767
[TBL] [Abstract][Full Text] [Related]
22. Epigallocatechin-3-gallate potentiates the effect of curcumin in inducing growth inhibition and apoptosis of resistant breast cancer cells.
Wang S; Chen R; Zhong Z; Shi Z; Chen M; Wang Y
Am J Chin Med; 2014; 42(5):1279-300. PubMed ID: 25242081
[TBL] [Abstract][Full Text] [Related]
23. Coencapsulated doxorubicin and bromotetrandrine lipid nanoemulsions in reversing multidrug resistance in breast cancer in vitro and in vivo.
Cao X; Luo J; Gong T; Zhang ZR; Sun X; Fu Y
Mol Pharm; 2015 Jan; 12(1):274-86. PubMed ID: 25469833
[TBL] [Abstract][Full Text] [Related]
24. Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene.
Xu HB; Li L; Fu J; Mao XP; Xu LZ
Pharmacology; 2012; 89(5-6):303-12. PubMed ID: 22573000
[TBL] [Abstract][Full Text] [Related]
25. Suppression of NF-κB signaling and P-glycoprotein function by gambogic acid synergistically potentiates adriamycin -induced apoptosis in lung cancer.
Wang LH; Yang JY; Yang SN; Li Y; Ping GF; Hou Y; Cui W; Wang ZZ; Xiao W; Wu CF
Curr Cancer Drug Targets; 2014; 14(1):91-103. PubMed ID: 24245692
[TBL] [Abstract][Full Text] [Related]
26. Gambogic acid, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells.
Wang T; Wei J; Qian X; Ding Y; Yu L; Liu B
Cancer Lett; 2008 Apr; 262(2):214-22. PubMed ID: 18248784
[TBL] [Abstract][Full Text] [Related]
27. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
Zhong T; Xu F; Xu J; Liu L; Chen Y
Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
[TBL] [Abstract][Full Text] [Related]
28. Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells.
Abdin SM; Tolba MF; Zaher DM; Omar HA
Chem Biol Interact; 2021 May; 340():109450. PubMed ID: 33775688
[TBL] [Abstract][Full Text] [Related]
29. Miltirone Is a Dual Inhibitor of P-Glycoprotein and Cell Growth in Doxorubicin-Resistant HepG2 Cells.
Zhou X; Wang Y; Lee WY; Or PM; Wan DC; Kwan YW; Yeung JH
J Nat Prod; 2015 Sep; 78(9):2266-75. PubMed ID: 26339922
[TBL] [Abstract][Full Text] [Related]
30. Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux.
Pan G; Li T; Zeng Q; Wang X; Zhu Y
Molecules; 2016 Feb; 21(2):. PubMed ID: 26861264
[TBL] [Abstract][Full Text] [Related]
31. Reactive oxygen species accumulation contributes to gambogic acid-induced apoptosis in human hepatoma SMMC-7721 cells.
Nie F; Zhang X; Qi Q; Yang L; Yang Y; Liu W; Lu N; Wu Z; You Q; Guo Q
Toxicology; 2009 Jun; 260(1-3):60-7. PubMed ID: 19464570
[TBL] [Abstract][Full Text] [Related]
32. By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells.
Tsubaki M; Komai M; Itoh T; Imano M; Sakamoto K; Shimaoka H; Takeda T; Ogawa N; Mashimo K; Fujiwara D; Mukai J; Sakaguchi K; Satou T; Nishida S
Leuk Res; 2014 Jan; 38(1):121-30. PubMed ID: 24239173
[TBL] [Abstract][Full Text] [Related]
33. Parthenolide reverses doxorubicin resistance in human lung carcinoma A549 cells by attenuating NF-κB activation and HSP70 up-regulation.
Xin Y; Yin F; Qi S; Shen L; Xu Y; Luo L; Lan L; Yin Z
Toxicol Lett; 2013 Aug; 221(2):73-82. PubMed ID: 23792430
[TBL] [Abstract][Full Text] [Related]
34. Enhanced Reactive Oxygen Species Generation by Mitochondria Targeting of Anticancer Drug To Overcome Tumor Multidrug Resistance.
Liu Y; Zhou Z; Lin X; Xiong X; Zhou R; Zhou M; Huang Y
Biomacromolecules; 2019 Oct; 20(10):3755-3766. PubMed ID: 31465208
[TBL] [Abstract][Full Text] [Related]
35. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
[TBL] [Abstract][Full Text] [Related]
36. Multifunctional nanoparticles improve therapeutic effect for breast cancer by simultaneously antagonizing multiple mechanisms of multidrug resistance.
Yin Q; Shen J; Zhang Z; Yu H; Chen L; Gu W; Li Y
Biomacromolecules; 2013 Jul; 14(7):2242-52. PubMed ID: 23682680
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of the P-glycoprotein relevant for multidrug resistance by intracellular acidification through the crosstalk of MAPK signaling pathways.
Jin W; Lu Y; Li Q; Wang J; Zhang H; Chang G; Lin Y; Pang T
Int J Biochem Cell Biol; 2014 Sep; 54():111-21. PubMed ID: 25043687
[TBL] [Abstract][Full Text] [Related]
38. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells.
Minko T; Batrakova EV; Li S; Li Y; Pakunlu RI; Alakhov VY; Kabanov AV
J Control Release; 2005 Jul; 105(3):269-78. PubMed ID: 15939500
[TBL] [Abstract][Full Text] [Related]
39. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W
J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]